Design of efficient computational workflows for in silico drug repurposing.

Here, we provide a comprehensive overview of the current status of in silico repurposing methods by establishing links between current technological trends, data availability and characteristics of the algorithms used in these methods. Using the case of the computational repurposing of fasudil as an alternative autophagy enhancer, we suggest a generic modular organization of a repurposing workflow. We also review 3D structure-based, similarity-based, inference-based and machine learning (ML)-based methods. We summarize the advantages and disadvantages of these methods to emphasize three current technical challenges. We finish by discussing current directions of research, including possibilities offered by new methods, such as deep learning.

[1]  Jun Zou,et al.  Advanced Systems Biology Methods in Drug Discovery and Translational Biomedicine , 2013, BioMed research international.

[2]  Elena Marchiori,et al.  Gaussian interaction profile kernels for predicting drug-target interaction , 2011, Bioinform..

[3]  S. Arnold,et al.  Repurposing Diabetes Drugs for Brain Insulin Resistance in Alzheimer Disease , 2014, Diabetes.

[4]  Guanghui Hu,et al.  Human Disease-Drug Network Based on Genomic Expression Profiles , 2009, PloS one.

[5]  Sunghoon Kim,et al.  Rational drug repositioning guided by an integrated pharmacological network of protein, disease and drug , 2012, BMC Systems Biology.

[6]  A. Butte,et al.  Leveraging big data to transform target selection and drug discovery , 2016, Clinical pharmacology and therapeutics.

[7]  Fei Luo,et al.  Pairwise input neural network for target-ligand interaction prediction , 2014, 2014 IEEE International Conference on Bioinformatics and Biomedicine (BIBM).

[8]  Francesca Spyrakis,et al.  Comparing Drug Images and Repurposing Drugs with BioGPS and FLAPdock: The Thymidylate Synthase Case , 2016, ChemMedChem.

[9]  Yanli Wang,et al.  Pathway Analysis for Drug Repositioning Based on Public Database Mining , 2014, J. Chem. Inf. Model..

[10]  P. Bork,et al.  Drug Target Identification Using Side-Effect Similarity , 2008, Science.

[11]  Shangbo Zhou,et al.  X-TREPAN: a multi class regression and adapted extraction of comprehensible decision tree in artificial neural networks , 2015, ArXiv.

[12]  Meir Glick,et al.  Prediction of Biological Targets for Compounds Using Multiple-Category Bayesian Models Trained on Chemogenomics Databases , 2006, J. Chem. Inf. Model..

[13]  Steffen Rendle,et al.  Factorization Machines with libFM , 2012, TIST.

[14]  Michael Gribskov,et al.  Use of Receiver Operating Characteristic (ROC) Analysis to Evaluate Sequence Matching , 1996, Comput. Chem..

[15]  Jun O. Liu,et al.  Recent Advances in Drug Repositioning for the Discovery of New Anticancer Drugs , 2014, International journal of biological sciences.

[16]  Zhiyong Lu,et al.  Pathway-based drug repositioning using causal inference , 2013, BMC Bioinformatics.

[17]  Yong Yu,et al.  SVDFeature: a toolkit for feature-based collaborative filtering , 2012, J. Mach. Learn. Res..

[18]  Russ B. Altman,et al.  Using Molecular Features of Xenobiotics to Predict Hepatic Gene Expression Response , 2013, J. Chem. Inf. Model..

[19]  Yves Morieux,et al.  Identifying R&D outliers , 2011, Nature Reviews Drug Discovery.

[20]  A. Barabasi,et al.  Network-based in silico drug efficacy screening , 2016, Nature Communications.

[21]  Luhua Lai,et al.  Deep Learning for Drug-Induced Liver Injury , 2015, J. Chem. Inf. Model..

[22]  Ivan Laptev,et al.  Learning and Transferring Mid-level Image Representations Using Convolutional Neural Networks , 2014, 2014 IEEE Conference on Computer Vision and Pattern Recognition.

[23]  Alexander A. Morgan,et al.  Supplementary Materials for Computational Repositioning of the Anticonvulsant Topiramate for Inflammatory Bowel Disease , 2011 .

[24]  Robert P. Sheridan,et al.  Deep Neural Nets as a Method for Quantitative Structure-Activity Relationships , 2015, J. Chem. Inf. Model..

[25]  J. Skolnick,et al.  Repurposing FDA-approved drugs for anti-aging therapies , 2016, Biogerontology.

[26]  H. Mucke,et al.  Sources and Targets for Drug Repurposing: Landscaping Transitions in Therapeutic Space. , 2015, Assay and drug development technologies.

[27]  M. Schroeder,et al.  Drug repositioning through incomplete bi-cliques in an integrated drug-target-disease network. , 2012, Integrative biology : quantitative biosciences from nano to macro.

[28]  P. Bork,et al.  Systematic identification of proteins that elicit drug side effects , 2013, Molecular systems biology.

[29]  Kenji Mizuguchi,et al.  Systems Biology Approaches to a Rational Drug Discovery Paradigm. , 2015, Current topics in medicinal chemistry.

[30]  Sergey Plis,et al.  Deep Learning Applications for Predicting Pharmacological Properties of Drugs and Drug Repurposing Using Transcriptomic Data. , 2016, Molecular pharmaceutics.

[31]  Vijay V. Raghavan,et al.  A critical investigation of recall and precision as measures of retrieval system performance , 1989, TOIS.

[32]  Dongsup Kim,et al.  Inference of Protein Complex Activities from Chemical-Genetic Profile and Its Applications: Predicting Drug-Target Pathways , 2008, PLoS Comput. Biol..

[33]  Yi-Cheng Zhang,et al.  Solving the apparent diversity-accuracy dilemma of recommender systems , 2008, Proceedings of the National Academy of Sciences.

[34]  A. Butte,et al.  A drug repositioning approach identifies tricyclic antidepressants as inhibitors of small cell lung cancer and other neuroendocrine tumors. , 2013, Cancer discovery.

[35]  J. Scannell,et al.  Diagnosing the decline in pharmaceutical R&D efficiency , 2012, Nature Reviews Drug Discovery.

[36]  Wyeth W Wasserman,et al.  Compensating for literature annotation bias when predicting novel drug-disease relationships through Medical Subject Heading Over-representation Profile (MeSHOP) similarity , 2013, BMC Medical Genomics.

[37]  L. Cardon,et al.  Use of genome-wide association studies for drug repositioning , 2012, Nature Biotechnology.

[38]  Shiwen Zhao,et al.  A co-module approach for elucidating drug-disease associations and revealing their molecular basis , 2012, Bioinform..

[39]  R. Sharan,et al.  PREDICT: a method for inferring novel drug indications with application to personalized medicine , 2011, Molecular systems biology.

[40]  A. Barabasi,et al.  Drug—target network , 2007, Nature Biotechnology.

[41]  Jianxin Chen,et al.  Matrix Factorization-Based Prediction of Novel Drug Indications by Integrating Genomic Space , 2015, Comput. Math. Methods Medicine.

[42]  Juho Rousu,et al.  Identification of drug candidates and repurposing opportunities through compound–target interaction networks , 2015, Expert opinion on drug discovery.

[43]  Dominique L. Monnet,et al.  Priority Medicines for Europe and the World , 2005 .

[44]  Natalia Novac,et al.  Challenges and opportunities of drug repositioning. , 2013, Trends in pharmacological sciences.

[45]  S. Joshua Swamidass,et al.  Modeling Epoxidation of Drug-like Molecules with a Deep Machine Learning Network , 2015, ACS central science.

[46]  Michael J. Keiser,et al.  Predicting new molecular targets for known drugs , 2009, Nature.

[47]  Pankaj Agarwal,et al.  Systematic Drug Repositioning Based on Clinical Side-Effects , 2011, PloS one.

[48]  Hui Zeng,et al.  Drug-Path: a database for drug-induced pathways , 2015, Database J. Biol. Databases Curation.

[49]  Joel Dudley,et al.  Exploiting drug-disease relationships for computational drug repositioning , 2011, Briefings Bioinform..

[50]  Kejian Wang,et al.  Opportunities for Web-based Drug Repositioning: Searching for Potential Antihypertensive Agents with Hypotension Adverse Events , 2016, Journal of medical Internet research.

[51]  Hui Liu,et al.  Improving compound–protein interaction prediction by building up highly credible negative samples , 2015, Bioinform..

[52]  Chee Keong Kwoh,et al.  Drug-target interaction prediction by learning from local information and neighbors , 2013, Bioinform..

[53]  Khader Shameer,et al.  In silico methods for drug repurposing and pharmacology , 2016, Wiley interdisciplinary reviews. Systems biology and medicine.

[54]  M. Kohandel,et al.  Tumor deconstruction as a tool for advanced drug screening and repositioning. , 2016, Pharmacological research.

[55]  Salvatore Alaimo,et al.  Drug–target interaction prediction through domain-tuned network-based inference , 2013, Bioinform..

[56]  D. Rubinsztein,et al.  Raised intracellular glucose concentrations reduce aggregation and cell death caused by mutant huntingtin exon 1 by decreasing mTOR phosphorylation and inducing autophagy. , 2003, Human molecular genetics.

[57]  Tudor I. Oprea,et al.  ChemInform Abstract: Quantifying the Relationships among Drug Classes. , 2008 .

[58]  M. Poirot,et al.  Tamoxifen and AEBS ligands induced apoptosis and autophagy in breast cancer cells through the stimulation of sterol accumulation , 2009, Autophagy.

[59]  Lin He,et al.  DRAR-CPI: a server for identifying drug repositioning potential and adverse drug reactions via the chemical–protein interactome , 2011, Nucleic Acids Res..

[60]  R. Langley,et al.  Repurposing Vitamin D as an Anticancer Drug. , 2016, Clinical oncology (Royal College of Radiologists (Great Britain)).

[61]  Diego di Bernardo,et al.  Identifying Network of Drug Mode of Action by Gene Expression Profiling , 2009, J. Comput. Biol..

[62]  M E J Newman,et al.  Modularity and community structure in networks. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[63]  H. Mucke.  Drug repurposing for vascular dementia: overview and current developments , 2016 .

[64]  Vijay S. Pande,et al.  Massively Multitask Networks for Drug Discovery , 2015, ArXiv.

[65]  Michael J. Keiser,et al.  Relating protein pharmacology by ligand chemistry , 2007, Nature Biotechnology.

[66]  Alex Zhavoronkov,et al.  Applications of Deep Learning in Biomedicine. , 2016, Molecular pharmaceutics.

[67]  E. Szabo,et al.  Repurposing old drugs to chemoprevention: the case of metformin. , 2016, Seminars in oncology.

[68]  Delbert Dueck,et al.  Clustering by Passing Messages Between Data Points , 2007, Science.

[69]  Funda Meric-Bernstam,et al.  Challenges and perspective of drug repurposing strategies in early phase clinical trials , 2015, Oncoscience.

[70]  Peter Woollard,et al.  An Integrated Data Driven Approach to Drug Repositioning Using Gene-Disease Associations , 2016, PloS one.

[71]  Zuping Zhang,et al.  Network-Based Inference Methods for Drug Repositioning , 2015, Comput. Math. Methods Medicine.

[72]  Tudor I. Oprea,et al.  Quantifying the Relationships among Drug Classes , 2008, J. Chem. Inf. Model..

[73]  Bernard H. Munos,et al.  How to Revive Breakthrough Innovation in the Pharmaceutical Industry , 2011, Science Translational Medicine.

[74]  Julio Saez-Rodriguez,et al.  DvD: An R/Cytoscape pipeline for drug repurposing using public repositories of gene expression data , 2012, Bioinform..

[75]  R. Graham,et al.  Spearman's Footrule as a Measure of Disarray , 1977 .

[76]  Qinghua Cui,et al.  Drug-repurposing identified the combination of Trolox C and Cytisine for the treatment of type 2 diabetes , 2014, Journal of Translational Medicine.

[77]  Lin Shili.  Space Oriented Rank-Based Data Integration , 2010 .

[78]  Antonio Lavecchia,et al.  In silico methods to address polypharmacology: current status, applications and future perspectives. , 2016, Drug discovery today.

[79]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[80]  Bruce Neal,et al.  Priority medicines for Europe and the world , 2004 .

[81]  Luonan Chen,et al.  Network-based drug repositioning. , 2013, Molecular bioSystems.

[82]  Shili Lin.  Space Oriented Rank-Based Data Integration , 2010, Statistical applications in genetics and molecular biology.

[83]  Navdeep Jaitly,et al.  Multi-task Neural Networks for QSAR Predictions , 2014, ArXiv.

[84]  A. Barabasi,et al.  Uncovering disease-disease relationships through the incomplete interactome , 2015, Science.

[85]  Yoshihiro Yamanishi,et al.  Prediction of drug–target interaction networks from the integration of chemical and genomic spaces , 2008, ISMB.

[86]  Ka-Lok Ng,et al.  Drug Repositioning Discovery for Early- and Late-Stage Non-Small-Cell Lung Cancer , 2014, BioMed research international.

[87]  Cristian R. Munteanu,et al.  MIND-BEST: Web server for drugs and target discovery; design, synthesis, and assay of MAO-B inhibitors and theoretical-experimental study of G3PDH protein from Trichomonas gallinae. , 2011, Journal of proteome research.

[88]  Philip E. Bourne,et al.  Drug Discovery Using Chemical Systems Biology: Weak Inhibition of Multiple Kinases May Contribute to the Anti-Cancer Effect of Nelfinavir , 2011, PLoS Comput. Biol..

[89]  João Rodrigues,et al.  Why and how have drug discovery strategies in pharma changed? What are the new mindsets? , 2016, Drug discovery today.

[90]  Evgeny Putin,et al.  Deep biomarkers of human aging: Application of deep neural networks to biomarker development , 2016, Aging.

[91]  Chuang Liu,et al.  Prediction of Drug-Target Interactions and Drug Repositioning via Network-Based Inference , 2012, PLoS Comput. Biol..

[92]  Michal Magid-Slav,et al.  Identification of Common Biological Pathways and Drug Targets Across Multiple Respiratory Viruses Based on Human Host Gene Expression Analysis , 2012, PloS one.

[93]  Paul A Clemons,et al.  The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease , 2006, Science.

[94]  Salvatore Alaimo,et al.  Recommendation Techniques for Drug-Target Interaction Prediction and Drug Repositioning. , 2016, Methods in molecular biology.

[95]  Yoshihiro Yamanishi,et al.  Supervised prediction of drug–target interactions using bipartite local models , 2009, Bioinform..

[96]  Therapeutic Drug Repurposing, Repositioning and Rescue , 2022 .

[97]  S. Brunak,et al.  Generating Genome‐Scale Candidate Gene Lists for Pharmacogenomics , 2009, Clinical pharmacology and therapeutics.

[98]  Inna Kuperstein,et al.  Network-based approaches for drug response prediction and targeted therapy development in cancer. , 2015, Biochemical and biophysical research communications.

[99]  T. Ashburn,et al.  Drug repositioning: identifying and developing new uses for existing drugs , 2004, Nature Reviews Drug Discovery.

[100]  S. Hochreiter,et al.  DeepTox: Toxicity prediction using deep learning , 2017 .

[101]  R. Tagliaferri,et al.  Discovery of drug mode of action and drug repositioning from transcriptional responses , 2010, Proceedings of the National Academy of Sciences.

[102]  Alexander A. Morgan,et al.  Discovery and Preclinical Validation of Drug Indications Using Compendia of Public Gene Expression Data , 2011, Science Translational Medicine.

[103]  Alexander A. Morgan,et al.  Computational Repositioning of the Anticonvulsant Topiramate for Inflammatory Bowel Disease , 2011, Science Translational Medicine.